Drug recall D-0028-2026
Product
Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30
Reason for recall
Lack of Assurance of Sterility:
Lots and codes
Lot YJ0152, Expiry: 01/31/2028.
Recall details
- Recalling firm
- ASTRAZENECA PHARMACEUTICALS, Gaithersburg, MD
- Quantity
- 916 pre-filled syringes
- Distribution
- Nationwide in the U.S
- Type
- Voluntary: Firm initiated
- Recall initiated
- October 8, 2025
Related products
- Fasenra – drug information
- NDC 0310-1730 Fasenra · Benralizumab 30 mg/mL · AstraZeneca Pharmaceuticals LP
- NDC 0310-1830 Fasenra · Benralizumab 30 mg/mL · AstraZeneca Pharmaceuticals LP
- NDC 0310-1745 Fasenra · Benralizumab 10 mg/.5mL · AstraZeneca Pharmaceuticals LP